NeuroDawn Pharmaceutical
NeuroDawn Pharmaceutical develops new drugs that are designed to treat central nervous system diseases.
NeuroDawn Pharmaceutical is active in the biotechnology, health care, manufacturing, medical space based in Asia-Pacific (APAC), founded in 2020.
Within the biotechnology, health care, manufacturing, medical space, the company focuses on its core offering rather than a broad product line.
Asia-Pacific (APAC) is where the company is located.
Directory data places it at the Series_B stage.
Recorded headcount: c_00051_00100 employees.
It has disclosed roughly $370M in funding.
| Sector | Biotechnology, Health Care, Manufacturing, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2020 |
| Employees | c_00051_00100 |
| Stage | series_b |
| Total funding | $370,000,000 |
Website: www.neurodawn.cn
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account